Abstract
Cell-penetrating peptides (CPPs) have rapidly become a mainstay technology for facilitating the delivery of a wide variety of nanomaterials to cells and tissues. Currently, the library of CPPs to choose from is still limited, with the HIV TAT-derived motif still being the most used. Among the many materials routinely delivered by CPPs, nanoparticles are of particular interest for a plethora of labeling, imaging, sensing, diagnostic, and therapeutic applications. The development of nanoparticle-based technologies for many of these uses will require access to a much larger number of functional peptide motifs that can both facilitate cellular delivery of different types of nanoparticles to cells and be used interchangeably in the presence of other peptides and proteins on the same surface. Here, we evaluate the utility of four peptidyl motifs for their ability to facilitate delivery of luminescent semiconductor quantum dots (QDs) in a model cell culture system. We find that an LAH4 motif, derived from a membrane-inserting antimicrobial peptide, and a chimeric sequence that combines a sweet arrow peptide with a portion originating from the superoxide dismutase enzyme provide effective cellular delivery of QDs. Interestingly, a derivative of the latter sequence lacking just a methyl group was found to be quite inefficient, suggesting that even small changes can have significant functional outcomes. Delivery was effected using 1 h incubation with cells, and fluorescent counterstaining strongly suggests an endosomal uptake process that requires a critical minimum number or ratio of peptides to be displayed on the QD surface. Concomitant cytoviability testing showed that the QD–peptide conjugates are minimally cytotoxic in the model COS-1 cell line tested. Potential applications of these peptides in the context of cellular delivery of nanoparticles and a variety of other (bio)molecules are discussed.
Similar content being viewed by others
References
Ho YP, Leong KW (2010) Nanoscale 2:60–68
Janib SM, Moses AS, MacKay JA (2010) Adv Drug Deliv Rev 62:1052–1063
Delehanty JB, Boeneman K, Bradburne CE, Robertson K, Medintz IL (2009) Expert Opin Drug Deliv 6:1091–1112
Delehanty JB, Mattoussi H, Medintz IL (2009) Anal Bioanal Chem 393:1091–1105
Algar WR, Prasuhn DE, Stewart MH, Jennings TL, Blanco-Canosa JB, Dawson PE, Medintz IL (2009) Bioconjugate Chem 22:825–858
Sapsford KE, Algar WR, Berti L, Boeneman Gemmill K, Casey BJ, Oh E, Stewart MH, Medintz IL (2013) Chem Rev 113:1904–2074
Duncan R, Richardson SC (2012) Mol Pharm 9:2380–2042
Licht SS, Sonnleitner A, Weiss S, Schultz PG (2003) Biochemistry 42:2916–2925
Delehanty JB, Bradburne CE, Boeneman K, Susumu K, Farrell D, Mei BC, Blanco-Canosa JB, Dawson G, Dawson PE, Mattoussi Medintz IL (2010) Integr Biol 2:265–277
Algar WR, Susumu K, Delehanty JB, Medintz IL (2011) Anal Chem 83:8826–8837
Walters R, Kraig RP, Medintz I, Delehanty JB, Stewart MH, Susumu K, Huston AL, Dawson PE, Dawson G (2012) ASN Neuro 4:e00099
Boeneman Gemmill K, Delehanty JB, Blanco-Canosa JB, Susumu K, Stewart MH, Oh E, Huston AL, Dawson G, Ingale S, Walters R, Domowicz M, Deschamps JR, Algar WR, DiMaggio SC, Manono J, Spillmann CM, Thompson DA, Jennings TL, Dawson PE, Medintz IL (2013) ACS Nano (in press)
Delehanty JB, Medintz IL, Pons T, Brunel FM, Dawson PE, Mattoussi H (2006) Bioconjugate Chem 17:920–927
Blanco-Canosa JB, Medintz IL, Farrell D, Mattoussi H, Dawson PE (2010) J Am Chem Soc 132:10027–10033
Sapsford KE, Farrell D, Sun S, Rasooly A, Mattoussi H, Medintz IL (2009) Sens Actuators B Chem 139:13–21
Mei BC, Susumu K, Medintz IL, Delehanty JB, Mountziaris TJ, Mattoussi H (2008) J Mater Chem 18:4949–4958
Mei BC, Susumu K, Medintz IL, Mattoussi H (2009) Nat Protoc 4:412–423
Oh E, Delehanty JB, Sapsford KE, Susumu K, Goswami R, Blanco-Canosa JB, Dawson PE, Granek J, Shoff M, Zhang Q, Goering PL, Huston A, Medintz IL (2011) ACS Nano 5:6434–6448
Sapsford KE, Pons T, Medintz IL, Higashiya S, Brunel FM, Dawson PE, Mattoussi H (2007) J Phys Chem C 111:11528–11538
Dennis AM, Sotto D, Mei BC, Medintz IL, Mattoussi H, Bao G (2010) Bioconjugate Chem 21:1160–1170
Liu W, Howarth M, Greytak AB, Zheng Y, Nocera DG, Ting AY, Bawendi MG (2008) J Am Chem Soc 130:1274–1284
Boeneman K, Prasuhn DE, Blanco-Canosa JB, Dawson PE, Melinger JS, Ancona M, Stewart MH, Susumu K, Huston A, Medintz IL (2010) J Am Chem Soc 132:18177–18190
Susumu K, Oh E, Delehanty JB, Blanco-Canosa JB, Johnson BJ, Jain V, Hervey WJ, Algar WR, Boeneman K, Dawson PE, Medintz IL (2011) J Am Chem Soc 133:9480–9496
Boeneman Gemmill K, Deschamps JR, Delehanty JB, Susumu K, Stewart MH, Glaven RH, Anderson GP, Goldman ER, Huston AL, Medintz IL (2013) Bioconjugate Chem 24:269–281
Boeneman K, Deschamps JR, Buckhout-White S, Prasuhn DE, Blanco-Canosa JB, Dawson PE, Stewart MH, Susumu K, Goldman ER, Ancona M, Medintz IL (2010) ACS Nano 4:7253–7266
Sapsford KE, Granek J, Deschamps JR, Boeneman K, Blanco-Canosa JB, Dawson PE, Susumu K, Stewart MH, Medintz IL (2011) ACS Nano 5:2687–2699
Lo SL, Wang S (2008) Biomaterials 29:2408e14
Midoux P, Monsigny M (1999) Bioconjugate Chem 10:406–411
Midoux P, Pichon C, Yaounac JJ, Jaffrès (2009) Br J Pharmacol 157:166-178
Leng Q, Scaria P, Zhu J, Ambulos N, Campbell P, Mixson AJ (2005) J Gene Med 7:977–986
Vogt TC, Bechinger B (1999) J Biol Chem 274:29115–29121
Mason AJ, Gasnier C, Bechinger B (2006) Antimicrob. Agents Chemother 50:3305–3311
Bechinger B (1996) J Mol Biol 263:768–775
De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F (2005) Biochem J 390:407–418
Crespo L, Sanclimens G, Montaner B, Perez-Tomas R, Royo M, Pons M, Albericio F, Giralt E (2002) J Am Chem Soc 124:8876–8883
Fernandez-Carneado J, Kogan MJ, Castel S, Giralt E (2004) Angew Chem Int Ed 43:1811–1814
Fernandez-Carneado J, Kogan MJ, Pujals S, Giralt E (2004) Biopolymers 76:196–203
Delehanty JB, Boeneman K, Bradburne CE, Robertson K, Bongard JE, Medintz IL (2010) Ther Deliv 1:411–433
Prasuhn DE, Deschamps JR, Susumu K, Stewart MH, Boeneman K, Blanco-Canosa JB, Dawson PE, Medintz IL (2010) Small 6:555–564
Medintz IL, Pons T, Delehanty JB, Susumu K, Brunel FM, Dawson PE, Mattoussi H (2008) Bioconjugate Chem 19:1785–1795
Cheng Y, Zak O, Aisen P, Harrison SC, Walz T (2004) Cell 116:565-576
Acknowledgments
The authors acknowledge NRL NSI and DTRA JSTO MIPR # B112582M for financial support. M.M. acknowledges funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 254897.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in the topical collection Optical Nanosensing in Cells with guest editor Francesco Baldini.
Kelly Boeneman Gemmill and Markus Muttenthaler contributed equally to this contribution.
Rights and permissions
About this article
Cite this article
Gemmill, K.B., Muttenthaler, M., Delehanty, J.B. et al. Evaluation of diverse peptidyl motifs for cellular delivery of semiconductor quantum dots. Anal Bioanal Chem 405, 6145–6154 (2013). https://doi.org/10.1007/s00216-013-6982-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-013-6982-2